Video game controversies: Difference between revisions

Studies have shown that video games, whether they are designed to be therapeutic or not, can be used to lower anxiety levels of those who suffer from chronic anxiety issues.<ref>{{cite journal|last1=Hsieh|first1=Ru-Lan|title=The Impact of Short Term Video Games on Performance among Children with Developmental Delays: A Randomized Controlled Trial|journal=PLOS ONE|date=2016|volume=11|issue=3|pages=e0149714|doi=10.1371/journal.pone.0149714|pmid=26983099|pmc=4794225|bibcode=2016PLoSO..1149714H|doi-access=free}}</ref> Furthermore, a study done on children with mental disorders showed specifically designed therapeutic games, that provide a "lifelike alternate reality", which can help treat problems such as schizophrenia, anxiety disorders, and [[ADHD]].<ref>Concepcion, H., (2017). "Video Game Therapy as an Intervention for Children With Disabilities Literature Review and Program Protocol". (Vol. 51, ''Therapeutic Recreation Journal'') Retrieved from http://search.lib.virginia.edu/articles/article?id=s3h%3A125493486 {{Webarchive|url=https://web.archive.org/web/20200922013430/https://search.lib.virginia.edu/articles/article?id=s3h%3A125493486 |date=2020-09-22 }}</ref> Following the release of positive first-line data in May 2023, Akili Interactive, Inc. announced that it will launch the video game to adults who wish to use it to treat attention deficit hyperactivity disorder. EndeavorOTC, the adult version of Akili's [[Food and Drug Administration|U.S. Food and Drug Administration]]-approved children's video game, is now available on the Apple App Store and can be used without a doctor's consultation or prescription. Previous versions of the game have been used in children's ADHD treatments<ref>{{Cite web |last=Aguilar |first=Mario |date=2023-06-07 |title=Akili Interactive releases video game treatment for adult ADHD with no prescription required |url=https://www.statnews.com/2023/06/07/adhd-akili-fda-adults-game-endeavorrx/ |access-date=2024-04-08 |website=STAT |language=en-US}}</ref>.